New cancer pill tested in patients who ran out of options
Disease control
Completed
This early-stage study tested the safety and optimal dosing of an experimental oral medication called Q702 in patients with advanced solid tumors. The trial involved 51 adults whose cancers had progressed despite standard treatments or who had no effective standard options availa…
Phase: PHASE1 • Sponsor: Qurient Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 01:12 UTC